Pioneering Stem Cell Altruism Research for Humanity
A Scientific and Industrial Research Organization (SIRO) certified laboratory working on cancer and infectious diseases.
Science that starts with patients and stays accountable to them.
KaviKrishna Laboratory carries out stem cell altruism research focused on diagnostic and therapeutic advances against cancer and infectious diseases.
We operate mainly from the KTC centre on College Road, Sualkuchi. Starting its operations informally in 1994, KTC formally registered under KaviKrishna NGO in 2010, and follows up with cancer patients every day.
More about us
Cancer and infectious diseases leave too many patients without access to expert care.
Specialist diagnosis and research capacity are concentrated far from the communities that need them. By pairing a research laboratory with a free patient consultancy centre, we bring scientific advances closer to the people they are meant to serve.
Diagnostics
Better ways to detect cancer and infectious disease early.
Therapeutics
Stem cell based approaches towards treatment.
Education
PhD programs that grow advanced research skills.
Patient care
Daily follow-up of patients at the KTC centre.
32+
Years of service
Operating from the KTC centre in Sualkuchi since 1994, formally registered under KaviKrishna NGO in 2010.
8
Research projects
Ongoing and completed work on cancer and infectious diseases.
17
Publications
Peer-reviewed papers from our scientists and collaborators.
16
Facilities
Laboratory facilities that support our research.
From the bench to the bedside
Our stem cell research team works on diagnostic and therapeutic advances, and carries what it learns into the KTC centre in Sualkuchi, where patients are followed up and examined every day.
Growing researchers, serving communities
Our academic programs train scientists in stem cell altruism, while our free consultancy service keeps the laboratory grounded in the needs of cancer patients from all over Assam.
News Medical Life Sciences · 10 May, 2020
COVID-19 could accelerate activation of dormant tuberculosis (TB)
The ongoing COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has thrown much of the world into disarray, with over 4 million people reported infected and well over 282,000 deaths. A new study published on the preprint server bioRxiv* in May 2020 suggests that the long-term impact of the virus could include activation of dormant bacterial infections like tuberculosis (TB).
United News of India · 05 August, 2019
Standard cancer treatment protocol to ease patient's woes
With Assam being one of the states with high incidence of cancer cases and high mortality of cancer patients due to lack of treatment or late diagnosis, absence of standard treatment protocol has further compounded the problem. Physician-scientist Dr Bikul Das, who has been closely related with research in cancer stem cell, said his interaction with cancer patients of the state for nearly a decade has revealed the lack of a standard treatment protocol, which has increased the problem further.
TNM NEWS Desk · 04 July, 2019
Altruistic behavior detected in Cancer Stems Cells by Guwahati lab
Researchers at KaviKrishna Lab in Guwahati, Assam, led by Bikul Das, have discovered that cancer stem cells (CSCs) activate a stemness pathway that helps them evade chemotherapy and radiotherapy. This pathway, similar to one used by embryonic stem cells for altruistic behavior, suggests that biological altruism might play a role in cancer growth. Published in Cancer Research, the study shows that CSCs maintain a stable, low frequency among cancer cells by possibly hijacking the HIF-2alpha stemness pathway. This discovery could change our understanding of how cancer grows and is maintained. The research was conducted in collaboration with Stanford University and funded by the KaviKrishna Foundation, the Laurel Foundation, and the NIH.
